Newsflash for the Snoozers - Part 19

Monday, 8th August 2016 09:55 - by Moosh

Beximco Pharma (BXP) BXP informed the market that it has commenced exporting carvedilol to the US (5 August 2016) – the first Bangladeshi pharmaceutical company to do so and the market received this news positively. With the mid-price market close for BXP at 35.625p on 5 August 2016, it still remains at a massive discount to the BXP share price for its listing in Dhaka (currently the equivalent of just over ~80p!!).

I feel this represents a big opportunity for investors who like the safety of defensive stocks like pharmaceuticals, especially one like BXP which has been comfortably profitable and dividend paying for many years, and growing in profit too.

Carillion (CLLN)

With the PE ratio for CLLN sitting comfortably in the undervalued region of below 10, also with a handsome dividend yield, CLLN recently informed the market of a number of projects:

-          Award of support services contracts worth up to £600m

-          Joint venture with Irish Schools Bundle 5 Public Partnership project  worth up to £190m

-          Joint venture with NSP Maritime Link for £86m

If you like profitable dividend payers, then add CLLN to your watchlist!

The Writer's views are their own, not a representation of London South East's. No advice is inferred or given. If you require financial advice, please seek an Independent Financial Adviser.